Fingerprint
Dive into the research topics of 'Pembrolizumab alone or in combination with chemotherapy as first-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma: results from the phase II nonrandomized KEYNOTE-059 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically